Maynard Um
-
-
-
-
-
-
-
Lunai Bioworks reports tumor regression in preclinical pancreatic cancer study
-
-
-
-
-
-
-
Lunai Bioworks completes rebrand and 10:1 reverse stock split
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

